Literature DB >> 26358949

[Principles and fields of application of screening procedures].

M Blettner1, C Spix2,3.   

Abstract

This article explains some important concepts of screening and early detection. It also discusses under which circumstances screening is useful, who can profit from screening and which persons may be at risk from screening procedures. Before the introduction of a screening program, empirical studies on the effectiveness are necessary to evaluate whether a screening program could be successful.

Entities:  

Keywords:  Benefit-risk assessment; Early detection of disease; Evaluation, screening program; Screening; Sensitivity and specificity

Mesh：

Year:  2015        PMID： 26358949     DOI： 10.1007/s00108-015-3736-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  10 in total

Review 1.  Principles of cancer screening: lessons from history and study design issues.

Authors:  Jennifer M Croswell; David F Ransohoff; Barnett S Kramer
Journal:  Semin Oncol       Date:  2010-06       Impact factor: 4.929

2.  Neuroblastoma screening at one year of age.

Authors:  Freimut H Schilling; Claudia Spix; Frank Berthold; Rudolf Erttmann; Natalja Fehse; Barbara Hero; Gisela Klein; Johannes Sander; Kerstin Schwarz; Joern Treuner; Ulrich Zorn; Joerg Michaelis
Journal:  N Engl J Med       Date:  2002-04-04       Impact factor: 91.245

3.  Screening: part 19 of a series on evaluation of scientific publications.

Authors:  Claudia Spix; Maria Blettner
Journal:  Dtsch Arztebl Int       Date:  2012-05-25       Impact factor: 5.594

4.  Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials.

Authors:  Matthew Burnell; Aleksandra Gentry-Maharaj; Andy Ryan; Sophia Apostolidou; Mariam Habib; Jatinderpal Kalsi; Steven Skates; Mahesh Parmar; Mourad W Seif; Nazar N Amso; Keith Godfrey; David Oram; Jonathan Herod; Karin Williamson; Howard Jenkins; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Simon Leeson; Derek Cruickshank; Stuart Campbell; Lesley Fallowfield; Ian Jacobs; Usha Menon
Journal:  Trials       Date:  2011-03-01       Impact factor: 2.279

5.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

6.  Epidemiology and quality control of 245 000 outpatient colonoscopies.

Authors:  Ulrich Mansmann; Alexander Crispin; Volkmar Henschel; Christine Adrion; Volker Augustin; Berndt Birkner; Axel Munte
Journal:  Dtsch Arztebl Int       Date:  2008-06-13       Impact factor: 5.594

7.  [Participation in cancer screening in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  A Starker; A-C Saß
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

8.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

9.  Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.

Authors:  Rebecca K Simmons; Justin B Echouffo-Tcheugui; Stephen J Sharp; Lincoln A Sargeant; Kate M Williams; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  Lancet       Date:  2012-10-04       Impact factor: 79.321

10.  Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Authors:  Anthony B Miller; Claus Wall; Cornelia J Baines; Ping Sun; Teresa To; Steven A Narod
Journal:  BMJ       Date:  2014-02-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.